Sorry had to re-post. Some people will focus on the spelling errors and not the content.
cheers
Its been well documented that major pharmas (not TEVA, I'm talking about the top 10 ) have plenty of cash and their product pipelines are looking very dim. I wonder, with MSB share price down to $4 and so many stage2 and 3 trials underway and people keep telling us on this thread that this is a blue chip stock in the making, it will be the biggest company in Australia, its 10 years ahead of any other stem cell company. Surely the Pharma must see value somewhere, or do they not understand stem cells either?? the only reasons i can think of are:
1. Professor is rejecting offers
2. Better value elsewhere
3. Waiting for the share price to drop further
Sorry - what are they waiting for
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |